Table 1 Estimated attributable fractions, deaths and registrations by cancer site in 2004 (2003 for registrations)

Cancer site				Attributable numbers
	Attributable fraction (%)			Deaths		Registrations
	Male	Female	Total	Male	Female	Male	Female
(a) Established carcinogens only (IARC Group 1, strong human evidence)
Bladder	1.3	0.6	1.0	40	10	89	17
Leukaemia	0.3	0.5	0.2	4	5	5	6
Lung	16.5	4.5	11.6	3137	599	3509	680
Mesothelioma	85–90‡	20–30‡	74–80	1450	75	1450†	75†
NMSC	11.8	3.0	8.4	38	6	3992	855
Sinonasal	34.1	10.8	23.4	24	6	74	18
Total
Based on deaths	6.0	1.0	3.6	4693	701
Based on registrations	5.4	1.0	3.2			9120	1652
(b) Established + uncertain carcinogens (IARC Group 1 and 2A, strong + suggestive human evidence)
Bladder	11.6	2.0	8.3	362	32	816	57
Leukaemia	2.7	0.8	1.7	58	11	93	15
Lung	21.6	5.5	15.0	4106	728	4594	826
Mesothelioma	98*	90*	97*	1650	270	1650†	270†
NMSC	11.8	3.0	8.4	38	6	3992	855
Sinonasal	64.3	18.4	43.3	45	11	140	31
Total:
Based on deaths	8.0	1.5	4.9	6259	1058
Based on registrations	6.7	1.2	4.0			11 284	2054
Total cancers in GB				78 237	71 666	167 506	164 586

*Includes cases described as due to paraoccupational or environmental exposure to asbestos.
†Taken as equal to attributable deaths for this short-survival cancer.
‡Mid-points of ranges used when estimating attributable numbers and combining results for mesothelioma with the other cancers.
GB, Great Britain; IARC, International Agency for Research on Cancer; NMSC, non-melanoma skin cancer.